Capvizr
THE DEAL, AT A GLANCE

Crystalys Therapeutics

From the announcement
01What happenedCrystalys Therapeutics raised $130M Series B, announced 2026-07-22From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersCrystalys Therapeutics' $130M Series B is an above-median Healthcare & Life Sciences capital allocation, supported by a trailing 30-day sector backdrop of 123 other…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Crystalys Therapeutics · Financing Record

Explore source-linked visual explanations for Crystalys Therapeutics. Unsupported claims are withheld while source review continues.

Record 8721 · Recorded date: 2026-07-22

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime